Dementia (Alzheimer’s Disease) – Comprehensive Medical Guide

Overview

Dementia is an umbrella term for a group of progressive neuro‑degenerative conditions that impair memory, thinking, language, judgment, and the ability to perform everyday activities. Alzheimer’s disease (AD) is the most common cause of dementia, accounting for 60–80 % of all cases.¹

Who it affects: While dementia can develop at any age, AD primarily affects older adults. The risk doubles roughly every five years after age 65. Approximately 1 in 10 people age 85 and older has Alzheimer’s disease.²

Prevalence: In the United States, an estimated 6.5 million people age 65 and older are living with Alzheimer’s disease (2023 data). Worldwide, more than 55 million individuals have dementia, and this number is projected to rise to 152 million by 2050 as life expectancy increases.³

Symptoms

Alzheimer’s disease progresses through three clinical stages – mild (early), moderate (middle), and severe (late). Symptoms may overlap, but the following list captures the most common manifestations at any stage.

Early (Mild) Stage

• Memory loss for recent events – forgetting conversations, appointments, or where objects were placed.
• Difficulty finding the right word – using vague terms or repeating oneself.
• Disorientation – getting lost in familiar neighborhoods or forgetting the day of the week.
• Impaired judgment – trouble handling money or making simple decisions.
• Changes in mood – increased anxiety, irritability, or mild depression.

Middle (Moderate) Stage

• Increasing memory gaps – forgetting personal history, family members’ names.
• Difficulty with complex tasks – problems cooking, paying bills, or using appliances.
• Language decline – sentences become short, may substitute nonsense words (paraphasia).
• Behavioral changes – wandering, agitation, suspiciousness, or repetitive questions.
• Sleep disturbances – frequent waking, daytime napping.

Late (Severe) Stage

• Severe memory loss – inability to recognize close relatives or oneself.
• Loss of physical abilities – difficulty walking, swallowing, or controlling bladder/bowel.
• Communication breakdown – reliance on non‑verbal cues; may become mute.
• Increased vulnerability – susceptibility to infections, pressure ulcers, and malnutrition.
• Profound personality changes – apathy, aggression, or delusional thinking.

Causes and Risk Factors

Alzheimer’s disease is multifactorial, involving genetic, environmental, and lifestyle components.

Pathophysiology

• Beta‑amyloid plaques – extracellular deposits that disrupt neuron communication.
• Neurofibrillary tangles – intracellular accumulation of hyperphosphorylated tau protein, leading to cell death.
• Neuroinflammation – chronic activation of the brain’s immune cells (microglia) that further damages neurons.

Genetic Factors

• APOE ε4 allele – the strongest known genetic risk factor; carriers have a 2–3‑fold increased risk.
• Rare early‑onset mutations – in APP, PSEN1, or PSEN2 genes, leading to disease onset before age 65.

Non‑Genetic Risk Factors

• Age (the most significant modifiable factor).
• Family history of Alzheimer’s disease.
• Cardiovascular risk factors – hypertension, hyperlipidemia, diabetes, smoking, and obesity.
• Low educational attainment or limited cognitively stimulating activities.
• Head trauma, especially with loss of consciousness.
• Depression or chronic stress.

Conversely, protective factors include regular physical activity, Mediterranean‑style diet, social engagement, and lifelong learning.⁴

Diagnosis

There is currently no single test that definitively diagnoses Alzheimer’s disease. Diagnosis is based on a combination of clinical evaluation, cognitive testing, imaging, and laboratory studies to rule out other causes.

Clinical Assessment

• Medical history – including symptom onset, progression, and family history.
• Physical & neurological exam – to assess motor function, reflexes, and sensory deficits.
• Mini‑Mental State Examination (MMSE) or MoCA – brief screening tools for cognitive impairment.

Neuropsychological Testing

Comprehensive batteries (e.g., the Alzheimer's Disease Assessment Scale‑Cognitive) evaluate memory, language, executive function, and visuo‑spatial abilities.

Laboratory Tests

• Blood work (CBC, thyroid panel, vitamin B12, syphilis, HIV) to exclude reversible causes.
• Genetic testing for APOE status or early‑onset mutations when indicated.

Neuroimaging

• MRI – rules out stroke, tumor, or hydrocephalus; shows medial temporal lobe atrophy.
• CT scan – useful when MRI is unavailable.
• FDG‑PET – assesses glucose metabolism; hypometabolism in posterior cingulate and parietal lobes supports AD.
• Amyloid PET – visualizes amyloid plaques; increasingly used for diagnostic certainty.

Biomarkers (Emerging)

Analysis of cerebrospinal fluid (CSF) for reduced Aβ42 and elevated total‑tau/phospho‑tau provides supportive evidence. Blood‑based assays (e.g., plasma Aβ42/40 ratio) are under validation.⁵

Treatment Options

Alzheimer’s disease currently has no cure, but several interventions can slow progression, manage symptoms, and improve quality of life.

Pharmacologic Therapies

• Cholinesterase inhibitors – Donepezil, Rivastigmine, Galantamine. Indicated for mild to moderate AD; modestly improve cognition and daily functioning.
• NMDA‑receptor antagonist – Memantine. Used in moderate‑to‑severe AD; may reduce excitotoxicity.
• Combination therapy – Donepezil + Memantine is approved for severe disease.
• Disease‑modifying agents (investigational) – Anti‑amyloid monoclonal antibodies (e.g., aducanumab, lecanemab). Recently FDA‑approved with strict prescribing criteria; patients must be enrolled in a registry and monitored for amyloid‑related imaging abnormalities (ARIA).⁶

Non‑Pharmacologic Interventions

• **Cognitive stimulation therapy** – structured group activities that improve memory and mood.
• **Physical exercise** – aerobic activity 150 min/week shown to preserve hippocampal volume.
• **Sleep hygiene** – regular schedule, limiting caffeine, treating sleep apnea.
• **Nutrition** – Mediterranean/DASH diet rich in fruits, vegetables, fish, and olive oil.
• **Behavioral management** – identifying triggers for agitation, using redirection, maintaining routines.

Supportive Measures

• Occupational therapy for adaptive equipment (e.g., pill organizers, labeled drawers).
• Speech‑language therapy for communication difficulties.
• Social work assistance for legal planning (power of attorney, advance directives).

Living with Dementia (Alzheimer’s disease)

Daily life adjustments can preserve independence as long as possible and reduce caregiver stress.

Home Safety

• Remove tripping hazards; install grab bars in bathroom.
• Use nightlights, label switches, and keep frequently used items in the same place.
• Consider a medical alert system for emergencies.

Medication Management

• Use a weekly pill organizer or automated dispenser.
• Keep a medication list and involve a pharmacist in regular reviews.

Communication Tips

• Speak slowly, maintain eye contact, and give one instruction at a time.
• Validate feelings; avoid correcting every mistake.
• Use visual cues (pictures, calendars).

Routine & Structure

• Maintain consistent meal times, bedtime, and daily activities.
• Incorporate favorite hobbies (music, gardening) to promote engagement.

Caregiver Support

• Take regular respite breaks; join local or online support groups (Alzheimer’s Association, Dementia Friends).
• Seek professional respite services or home‑health aides when needed.
• Plan for future care—evaluate long‑term‑care options early.

Prevention

While age cannot be altered, evidence suggests several modifiable behaviors lower Alzheimer’s risk.

• Physical activity – at least 150 minutes of moderate aerobic exercise per week.
• Heart‑healthy diet – Mediterranean, DASH, or MIND diets rich in antioxidants and omega‑3 fatty acids.
• Cognitive engagement – lifelong learning, crossword puzzles, musical instrument, or language study.
• Social interaction – regular contact with friends/family reduces depression and isolation.
• Manage cardiovascular risk – control blood pressure, cholesterol, blood sugar, and quit smoking.
• Sleep – aim for 7–8 hours/night; treat obstructive sleep apnea promptly.
• Limit alcohol – moderate consumption (≤1 drink/day for women, ≤2 for men) or none.

Complications

If Alzheimer’s disease progresses without appropriate management, several serious complications may arise:

• Severe malnutrition and dehydration due to forgetting to eat or drink.
• Falls and fractures from gait instability and impaired judgment.
• Pressure ulcers from reduced mobility.
• Pneumonia – aspiration risk increases with dysphagia.
• Urinary tract infections – due to incontinence and catheter use.
• Psychiatric issues – depression, anxiety, psychosis, and aggressive behavior.
• Financial abuse – vulnerability to scams.

When to Seek Emergency Care

References

1. Alzheimer’s Association. 2024 Alzheimer’s Disease Facts and Figures. https://www.alz.org/alzheimers-dementia/facts-figures (accessed May 2026).
2. CDC. Alzheimer’s Disease Information for Public Health Professionals. https://www.cdc.gov/aging/pdf/alzheimers-disease.pdf (2023).
3. World Health Organization. Dementia Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/dementia (2024).
4. National Institute on Aging. Alzheimer’s Disease Fact Sheet. https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet (2023).
5. Mayo Clinic. Alzheimer’s Disease Diagnosis. https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/diagnosis-treatment/drc-20350453 (2024).
6. U.S. Food & Drug Administration. Clinical Trials and FDA Approval Process for Alzheimer’s Therapies. https://www.fda.gov/drugs/development-approval-process-drugs/clinical-trials-2024 (2024).